deltatrials
Completed NA INTERVENTIONAL 4-arm NCT02711293

The Impact of Home Delivery of Antiretroviral Therapy on Virological Suppression

The Impact of Home Delivery of Antiretroviral Therapy on Virological Suppression: A Non-inferiority Cluster-randomized Controlled Trial in Dar es Salaam, Tanzania

Sponsor: Harvard School of Public Health (HSPH)

Updated 7 times since 2017 Last updated: Mar 2, 2018 Started: Mar 31, 2016 Primary completion: Feb 28, 2018 Completion: Feb 28, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Antiretroviral Therapy, Highly Active and Community Health Workers, this trial is completed. The trial is conducted by Harvard School of Public Health (HSPH) and has accumulated 7 data snapshots since 2016. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

~Jan 2017 – ~Mar 2018 · 14 months · monthly snapshotRecruiting~Mar 2018 – ~Jun 2018 · 3 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Mar 2022 · 14 months · monthly snapshotCompleted~Mar 2022 – ~Jul 2024 · 28 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 24 months · monthly snapshotCompleted

Change History

7 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Mar 2022 — Jul 2024 [monthly]

    Completed NA

  4. Jan 2021 — Mar 2022 [monthly]

    Completed NA

  5. Jun 2018 — Jan 2021 [monthly]

    Completed NA

Show 2 earlier versions
  1. Mar 2018 — Jun 2018 [monthly]

    Completed NA

    Status: RecruitingCompleted

  2. Jan 2017 — Mar 2018 [monthly]

    Recruiting NA

    First recorded

Mar 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Harvard School of Public Health (HSPH)
  • International Initiative for Impact Evaluation
  • Management and Development for Health
Data source: Harvard School of Public Health (HSPH)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations